PD(L)-1 Biomarker • PARP Biomarker • BRCA Biomarker • IO biomarker
|
PD-L1 (Programmed death ligand 1) • HRD (Homologous Recombination Deficiency) • BRCA (Breast cancer early onset) • CD4 (CD4 Molecule) • WNT5B (Wnt Family Member 5B)
|
PD-L1 expression • PD-L1 negative • BRCA mutation
|
Prosigna™ Breast Cancer Prognostic Gene Signature Assay
|
Keytruda (pembrolizumab) • Zejula (niraparib)